PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany

Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.205
https://www.valueinhealthjournal.com/article/S1098-3015(11)01767-0/fulltext
Section Title : Infection
Section Order : 182
First Page : A268
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01767-0&doi=10.1016/j.jval.2011.08.205
HEOR Topics :
Tags :
Regions :